European Leukemia Trial Registry
Trial: QOL II

More Details
Title Quality of Life and Symptoms in Patients With Newly Diagnosed MDS
Scientific Title Prognostic Significance and Longitudinal Assessment of Patient-reported Quality of Life and Symptoms in High-risk Myelodysplastic Syndromes. A Large-scale International Study.
Short Title QOL II
Trialgroup GIMEMA
Type of Trial NIS, prospective
Disease Myelodysplastic Syndrome(MDS) Intermedia II and high risk
Age -
Status No longer recruiting
Start of Recruitment 01.11.2008
Leader Efficace, PhD, Fabio
Shortprotocol Shortprotocol
created 08.03.2010 Irene Gleske
changed 01.06.2015 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org